Aviva
CORT icon

Aviva’s Corcept Therapeutics CORT Stock Holding History

Aviva’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Buy
+5,751
New +$347K ﹤0.01% 699
2026
Q1 		– Sell
-6,045
Closed -$210K – 864
2025
Q4 		$210K Sell
6,045
-381
-6% -$29.9K ﹤0.01% 864
2025
Q3 		$534K Sell
6,426
-137
-2% -$9.91K ﹤0.01% 709
2025
Q2 		$482K Sell
6,563
-3,805
-37% -$276K ﹤0.01% 764
2025
Q1 		$1.18M Sell
10,368
-588
-5% -$35.8K ﹤0.01% 613
2024
Q4 		$552K Sell
10,956
-6,371
-37% -$334K ﹤0.01% 785
2024
Q3 		$802K Sell
17,327
-3,893
-18% -$138K ﹤0.01% 626
2024
Q2 		$689K Sell
21,220
-5,265
-20% -$144K ﹤0.01% 680
2024
Q1 		$667K Buy
26,485
+4,072
+18% +$96.2K ﹤0.01% 749
2023
Q4 		$728K Buy
+22,413
New +$615K ﹤0.01% 724
2022
Q1 		– Sell
-127,855
Closed -$2.53M – 1069
2021
Q4 		$2.53M Buy
127,855
+48,808
+62% +$990K 0.01% 791
2021
Q3 		$1.56M Buy
+79,047
New +$1.65M 0.01% 876
2021
Q1 		– Sell
-70,676
Closed -$1.85M – 950
2020
Q4 		$1.85M Sell
70,676
-57,297
-45% -$1.21M 0.01% 691
2020
Q3 		$2.23M Sell
127,973
-8,376
-6% -$133K 0.01% 737
2020
Q2 		$2.29M Sell
136,349
-180,494
-57% -$2.54M 0.01% 699
2020
Q1 		$3.77M Buy
+316,843
New +$3.92M 0.03% 506

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aviva's CORT Position: Q2 2026 in Review

Aviva opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 5,751 shares worth $500K. The stake represents ﹤0.01% of the portfolio and ranks #699 among its holdings. This is a return to the name: Aviva previously reported a position in CORT as recently as Q4 2025.

Aviva first reported a position in CORT in Q1 2020 and has held it in 16 quarters since. The position peaked at $3.77M in Q1 2020. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Aviva held 5,751 shares of Corcept Therapeutics worth $500K as of Q2 2026.
  • Corcept Therapeutics was a new Aviva position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #699 holding.
  • Aviva first reported a position in Corcept Therapeutics in Q1 2020 and has held it in 16 quarters since.
  • Aviva's Corcept Therapeutics position peaked at $3.77M in Q1 2020.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.